Please select the option that best describes you:

What is the current opinion on G-CSF usage for AML patients during induction and consolidation phases of treatment?  

It used to be a contraindication for G-CSF use for AML patients, but currently, several protocols include it to decrease neutropenic duration.



Answer from: at Academic Institution
Comments
at Arnold Palmer Hospital Center for Children’s Cancer and Blood Disorders
Thank you very much, Dr. @Michele S. Redell! It is...
Sign in or Register to read more